4//SEC Filing
Richardson Peter C 4
Accession 0001209191-21-028856
CIK 0001016169other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 8:40 PM ET
Size
5.9 KB
Accession
0001209191-21-028856
Insider Transaction Report
Form 4
Richardson Peter C
EVP, R&D Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-26+59,179→ 59,179 totalExercise: $4.01Exp: 2031-04-26→ Common Stock (59,179 underlying)
Footnotes (2)
- [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F2]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001343502
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 8:40 PM ET
- Size
- 5.9 KB